SECENDS - MDT

2025

Q4 1 filings

Nov 18

Released Q2 FY26 Financial Results

8-K View →

Q3 1 filings

Aug 19

Q1 Earnings + Board Expansion

Q1 FY2026 results; Board expanded from 11 to 13 directors

8-K View →

Q2 1 filings

May 21

Q4 Earnings & Diabetes Spinoff

FY2025 results announced, Diabetes business separation into standalone public company

8-K View →

Q1 1 filings

Feb 18

Q3 FY2025 Earnings

Third quarter fiscal year 2025 financial results announced

8-K View →

2024

Q4 1 filings

Nov 19

Q2 FY2025 Earnings

Second quarter fiscal year 2025 financial results announced

8-K View →

Q3 1 filings

Aug 20

Q1 FY2025 Earnings

First quarter fiscal year 2025 financial results

8-K View →

Q2 1 filings

May 23

Q4 and Full Year FY2024 Earnings

Full year and fourth quarter fiscal year 2024 financial results announced

8-K View →

Q1 1 filings

Feb 20

Q3 Earnings & Executive Departure

Q3 FY2024 results + Robert J. White departing April 26

8-K View →